SIM
HAE icon

Spark Investment Management’s Haemonetics HAE Stock Holding History

Spark Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-25,700
Closed -$930K – 816
2016
Q3 		$930K Hold
25,700
– – 0.08% 363
2016
Q2 		$745K Buy
+25,700
New +$777K 0.07% 368

Other funds holding HAE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Spark Investment Management's HAE Position: Q4 2016 in Review

Spark Investment Management sold out of Haemonetics (HAE) in Q4 2016, closing a stake of 25,700 shares — an estimated $930K sold.

Spark Investment Management first reported a position in HAE in Q2 2016 and held it in 2 quarters. The position peaked at $930K in Q3 2016. 198 funds tracked by Wall St. Rank hold HAE as of Q4 2016.

  • Spark Investment Management reported no remaining Haemonetics position as of Q4 2016 after selling out during the quarter.
  • Spark Investment Management sold 25,700 Haemonetics shares in Q4 2016, an estimated $930K.
  • Spark Investment Management first reported a position in Haemonetics in Q2 2016 and held it in 2 quarters.
  • Spark Investment Management's Haemonetics position peaked at $930K in Q3 2016.
  • 198 funds tracked by Wall St. Rank held Haemonetics as of Q4 2016.

Based on Spark Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.